News

In honor of this year's World Sickle Cell Day, columnist Dunstan Nicol-Wilson recognizes several organizations that are making a difference.
BEAM-101, a genetically modified cell therapy for sickle cell, is designed to turn on HbF to counteract mutated adult ...
Even if children with sickle cell disease appear asymptomatic, it's still crucial to provide proper care, says columnist.
For columnist Mary Shaniqua, who tracks her health closely, not being able to discern the causes of a sickle cell crisis is ...
The FDA has granted orphan drug status to rilzabrutinib, an investigational therapy to prevent pain crises in sickle cell ...
An algorithm is helping to reduce the number of unnecessary hospital admissions for children with sickle cell.